Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-018119)

Filing Details

Accession Number:: 0001209191-13-018119
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-03-22 19:32:47
Reporting Period:: 2013-03-22

Filing Date:: 2013-03-22
Accepted Time:: 2013-03-22 19:32:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1411158	Anacor Pharmaceuticals Inc	ANAC	Pharmaceutical Preparations (2834)	251854385

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1435944	Lucy Shapiro	C/O Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto CA 94303		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-03-22	10,000	$6.94	307,416	No	4	S	Indirect	MCADAMS-SHAPIRO FAMILY TRUST DTD MAY 24, 1999
Common Stock	Disposition	2013-03-22	10,000	$6.88	297,416	No	4	S	Indirect	MCADAMS-SHAPIRO FAMILY TRUST DTD MAY 24, 1999

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	MCADAMS-SHAPIRO FAMILY TRUST DTD MAY 24, 1999
No	4	S	Indirect	MCADAMS-SHAPIRO FAMILY TRUST DTD MAY 24, 1999

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	36,248	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2012.